| Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study MJ Armstrong, P Gaunt, GP Aithal, D Barton, D Hull, R Parker, ... The Lancet 387 (10019), 679-690, 2016 | 2092 | 2016 |
| 11β-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response JW Tomlinson, EA Walker, IJ Bujalska, N Draper, GG Lavery, MS Cooper, ... Endocrine reviews 25 (5), 831-866, 2004 | 1226 | 2004 |
| Association between premature mortality and hypopituitarism JW Tomlinson, N Holden, RK Hills, K Wheatley, RN Clayton, AS Bates, ... The Lancet 357 (9254), 425-431, 2001 | 1198 | 2001 |
| Pathogenesis of non-alcoholic fatty liver disease JK Dowman, JW Tomlinson, PN Newsome QJM: An International Journal of Medicine 103 (2), 71-83, 2010 | 1106 | 2010 |
| Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence S Thangaratinam, E Rogozińska, K Jolly, S Glinkowski, T Roseboom, ... Bmj 344, 2012 | 1069 | 2012 |
| Non-alcoholic fatty liver disease and diabetes JM Hazlehurst, C Woods, T Marjot, JF Cobbold, JW Tomlinson Metabolism 65 (8), 1096-1108, 2016 | 619 | 2016 |
| Systematic review: the diagnosis and staging of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis JK Dowman, JW Tomlinson, PN Newsome Alimentary pharmacology & therapeutics 33 (5), 525-540, 2011 | 470 | 2011 |
| Mortality in patients with pituitary disease M Sherlock, J Ayuk, JW Tomlinson, AA Toogood, A Aragon-Alonso, ... Endocrine reviews 31 (3), 301-342, 2010 | 466 | 2010 |
| Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis MJ Armstrong, D Hull, K Guo, D Barton, JM Hazlehurst, LL Gathercole, ... Journal of hepatology 64 (2), 399-408, 2016 | 464 | 2016 |
| Diagnosis and management of adrenal insufficiency I Bancos, S Hahner, J Tomlinson, W Arlt The lancet Diabetes & endocrinology 3 (3), 216-226, 2015 | 447 | 2015 |
| Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study AJ Sinclair, MA Burdon, PG Nightingale, AK Ball, P Good, TD Matthews, ... Bmj 341, 2010 | 383 | 2010 |
| Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency N Draper, EA Walker, IJ Bujalska, JW Tomlinson, SM Chalder, W Arlt, ... Nature genetics 34 (4), 434-439, 2003 | 373 | 2003 |
| Interventions to reduce or prevent obesity in pregnant women: a systematic review. S Thangaratinam, E Rogozińska, K Jolly, S Glinkowski, W Duda, ... NIHR Health Technology Assessment programme: Executive Summaries, 2012 | 349 | 2012 |
| Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione MW O'Reilly, AE Taylor, NJ Crabtree, BA Hughes, F Capper, RK Crowley, ... The journal of clinical endocrinology & metabolism 99 (3), 1027-1036, 2014 | 347 | 2014 |
| Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta‐analysis of the LEAD program MJ Armstrong, DD Houlihan, IA Rowe, WHO Clausen, B Elbrønd, ... Alimentary pharmacology & therapeutics 37 (2), 234-242, 2013 | 323 | 2013 |
| 11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess SA Morgan, EL McCabe, LL Gathercole, ZK Hassan-Smith, DP Larner, ... Proceedings of the National Academy of Sciences 111 (24), E2482-E2491, 2014 | 299 | 2014 |
| Regulation of expression of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines JW Tomlinson, J Moore, MS Cooper, I Bujalska, M Shahmanesh, C Burt, ... Endocrinology 142 (5), 1982-1989, 2001 | 299 | 2001 |
| Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism W Arlt, K Lang, AJ Sitch, AS Dietz, Y Rhayem, I Bancos, A Feuchtinger, ... JCI insight 2 (8), 2017 | 252 | 2017 |
| Expression of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity JW Tomlinson, B Sinha, I Bujalska, M Hewison, PM Stewart The Journal of Clinical Endocrinology & Metabolism 87 (12), 5630-5635, 2002 | 248 | 2002 |
| Androgen generation in adipose tissue in women with simple obesity–a site-specific role for 17β-hydroxysteroid dehydrogenase type 5 M Quinkler, B Sinha, JW Tomlinson, IJ Bujalska, PM Stewart, W Arlt Journal of Endocrinology 183 (2), 331-342, 2004 | 230 | 2004 |
